Literature DB >> 34533402

Why the diabetic heart is energy inefficient: a ketogenesis and ketolysis perspective.

Paras Kumar Mishra1.   

Abstract

Lack of glucose uptake compromises metabolic flexibility and reduces energy efficiency in the diabetes mellitus (DM) heart. Although increased use of fatty acid to compensate glucose substrate has been studied, less is known about ketone body metabolism in the DM heart. Ketogenic diet reduces obesity, a risk factor for T2DM. How ketogenic diet affects ketone metabolism in the DM heart remains unclear. At the metabolic level, the DM heart differs from the non-DM heart because of altered metabolic substrate and the T1DM heart differs from the T2DM heart because of insulin levels. How these changes affect ketone body metabolism in the DM heart are poorly understood. Ketogenesis produces ketone bodies by using acetyl-CoA, whereas ketolysis consumes ketone bodies to produce acetyl-CoA, showing their opposite roles in the ketone body metabolism. Cardiac-specific transgenic upregulation of ketogenesis enzyme or knockout of ketolysis enzyme causes metabolic abnormalities leading to cardiac dysfunction. Empirical evidence demonstrates upregulated transcription of ketogenesis enzymes, no change in the levels of ketone body transporters, very high levels of ketone bodies, and reduced expression and activity of ketolysis enzymes in the T1DM heart. Based on these observations, I hypothesize that increased transcription and activity of cardiac ketogenesis enzyme suppresses ketolysis enzyme in the DM heart, which decreases cardiac energy efficiency. The T1DM heart exhibits highly upregulated ketogenesis compared with the T2DM heart because of the lack of insulin, which inhibits ketogenesis enzyme.

Entities:  

Keywords:  Randle cycle; female; ketogenic diet; ketone body; metabolism

Mesh:

Substances:

Year:  2021        PMID: 34533402      PMCID: PMC8803309          DOI: 10.1152/ajpheart.00260.2021

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   5.125


  46 in total

1.  Studies on myocardial metabolism. VI. Myocardial metabolism in congestive failure.

Authors:  J M BLAIN; H SCHAFER; A L SIEGEL; R J BING
Journal:  Am J Med       Date:  1956-06       Impact factor: 4.965

2.  Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.

Authors:  Christian Wolfrum; Esra Asilmaz; Edlira Luca; Jeffrey M Friedman; Markus Stoffel
Journal:  Nature       Date:  2004-12-23       Impact factor: 49.962

3.  Role of diabetes in congestive heart failure: the Framingham study.

Authors:  W B Kannel; M Hjortland; W P Castelli
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

4.  Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome.

Authors:  Stephanie Kiencke; Rolf Handschin; Ruth von Dahlen; Jürgen Muser; Hans Peter Brunner-Larocca; Jörg Schumann; Barbara Felix; Kaspar Berneis; Peter Rickenbacher
Journal:  Eur J Heart Fail       Date:  2010-06-25       Impact factor: 15.534

Review 5.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Cell Metab       Date:  2017-02-07       Impact factor: 27.287

6.  Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.

Authors:  Davide Castagno; Jonathan Baird-Gunning; Pardeep S Jhund; Giuseppe Biondi-Zoccai; Michael R MacDonald; Mark C Petrie; Fiorenzo Gaita; John J V McMurray
Journal:  Am Heart J       Date:  2011-10-07       Impact factor: 4.749

7.  Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.

Authors:  Yamini S Levitzky; Michael J Pencina; Ralph B D'Agostino; James B Meigs; Joanne M Murabito; Ramachandran S Vasan; Caroline S Fox
Journal:  J Am Coll Cardiol       Date:  2008-01-22       Impact factor: 24.094

8.  CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis.

Authors:  Ele Ferrannini; Michael Mark; Eric Mayoux
Journal:  Diabetes Care       Date:  2016-07       Impact factor: 19.112

9.  Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling.

Authors:  Rebecca C Schugar; Ashley R Moll; D André d'Avignon; Carla J Weinheimer; Attila Kovacs; Peter A Crawford
Journal:  Mol Metab       Date:  2014-08-13       Impact factor: 7.422

Review 10.  Sex Differences of the Diabetic Heart.

Authors:  Natacha Fourny; Christophe Beauloye; Monique Bernard; Sandrine Horman; Martine Desrois; Luc Bertrand
Journal:  Front Physiol       Date:  2021-05-27       Impact factor: 4.566

View more
  3 in total

Review 1.  Guidelines on models of diabetic heart disease.

Authors:  Lisa C Heather; Anne D Hafstad; Ganesh V Halade; Romain Harmancey; Kimberley M Mellor; Paras K Mishra; Erin E Mulvihill; Miranda Nabben; Michinari Nakamura; Oliver J Rider; Matthieu Ruiz; Adam R Wende; John R Ussher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-06-03       Impact factor: 5.125

2.  Metabolites and Genes behind Cardiac Metabolic Remodeling in Mice with Type 1 Diabetes Mellitus.

Authors:  Tyler N Kambis; Hamid R Shahshahan; Paras K Mishra
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

3.  A 90-Day Safety Study of Meat from MSTN and FGF5 Double-Knockout Sheep in Wistar Rats.

Authors:  Yue Zhao; Mingming Chen; Yao Li; Xueling Xu; Sujun Wu; Zhimei Liu; Shiyu Qi; Guang Yi; Xiaosheng Zhang; Jinlong Zhang; Xiaofei Guo; Kun Yu; Shoulong Deng; Yan Li; Zhengxing Lian
Journal:  Life (Basel)       Date:  2022-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.